Aveanna Healthcare (NASDAQ:AVAH) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Aveanna Healthcare (NASDAQ:AVAH) was upgraded by analysts at Zacks Research from a "hold" rating to a "strong-buy" rating.
Aveanna Healthcare (NASDAQ:AVAH) had its price target raised by analysts at Barclays PLC from $9.00 to $11.00. They now have an "overweight" rating on the stock.
Is It Too Late To Consider Aveanna Healthcare Holdings (AVAH) After 1 Year 108% Surge? [Yahoo! Finance]
A Look At Aveanna Healthcare Holdings (AVAH) Valuation After Higher 2025 Guidance And New 2026 Targets [Yahoo! Finance]